Literature DB >> 12574616

Obesity drug pipeline not so fat.

Trisha Gura.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12574616     DOI: 10.1126/science.299.5608.849

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

Review 1.  Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity.

Authors:  D Cota; S Genghini; R Pasquali; U Pagotto
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

2.  The hormone ghrelin prevents traumatic brain injury induced intestinal dysfunction.

Authors:  Vishal Bansal; Seok Yong Ryu; Chelsea Blow; Todd Costantini; William Loomis; Brian Eliceiri; Andrew Baird; Paul Wolf; Raul Coimbra
Journal:  J Neurotrauma       Date:  2010-11-02       Impact factor: 5.269

3.  Substance P as a novel anti-obesity target.

Authors:  Iordanes Karagiannides; Daniel Torres; Yu-Hua Tseng; Collin Bowe; Eugenia Carvalho; Daniel Espinoza; Charalabos Pothoulakis; Efi Kokkotou
Journal:  Gastroenterology       Date:  2008-03       Impact factor: 22.682

4.  A combination of cytokines EGF and CNTF protects the functional beta cell mass in mice with short-term hyperglycaemia.

Authors:  Marie Lemper; Sofie De Groef; Geert Stangé; Luc Baeyens; Harry Heimberg
Journal:  Diabetologia       Date:  2016-06-18       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.